Unmasking of oestrogen-dependent changes in left ventricular structure and function in aged female rats: a potential model for pre-heart failure with preserved ejection fraction.
HFpEF
estrogens
fibrosis
fructose
heart failure
senile
Journal
The Journal of physiology
ISSN: 1469-7793
Titre abrégé: J Physiol
Pays: England
ID NLM: 0266262
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
20
11
2018
accepted:
24
01
2019
pubmed:
27
1
2019
medline:
18
7
2020
entrez:
26
1
2019
Statut:
ppublish
Résumé
Heart failure with preserved ejection fraction (HFpEF) is seen more frequently in older women; risk factors include age, hypertension and excess weight. No female animal models of early stage remodelling (pre-HFpEF) have examined the effects that the convergence of such factors have on cardiac structure and function. In this study, we demonstrate that ageing can lead to the development of mild chamber remodelling, diffuse fibrosis and loss of diastolic function. The loss of oestrogens further aggravates such changes by leading to a notable drop in cardiac output (while preserving normal ejection fraction) in the presence of diffuse fibrosis that is more predominant in endocardium and is accompanied by papillary fibrosis. Excess weight did not markedly aggravate such findings. This animal model recapitulates many of the features recognized in older, female HFpEF patients and thus, may serve to examine the effects of candidate therapeutic agents. Two-thirds of patients with heart failure with preserved ejection fraction (HFpEF) are older women, and risk factors include hypertension and excess weight/obesity. Pathophysiological factors that drive early disease development (before heart failure ensues) remain obscure and female animal models are lacking. The study evaluated the intersecting roles of ageing, oestrogen depletion and excess weight on altering cardiac structure/function. Female, 18-month-old, Fischer F344 rats were divided into an aged group, aged + ovariectomy (OVX) and aged + ovariectomy + 10% fructose (OVF) in drinking water (n = 8-16/group) to induce weight gain. Left ventricular (LV) structure/function was monitored by echocardiography. At 22 months of age, animals were anaesthetized and catheter-based haemodynamics evaluated, followed by histological measures of chamber morphometry and collagen density. All aged animals developed hypertension. OVF animals increased body weight. Echocardiography only detected mild chamber remodelling with ageing while intraventricular pressure-volume loop analysis showed significant (P < 0.05) decreases vs. ageing in stroke volume (13% OVX and 15% for OVF), stroke work (34% and 52%) and cardiac output (29% and 27%), and increases in relaxation time (10% OVX) with preserved ejection fraction. Histology indicated papillary and interstitial fibrosis with ageing, which was higher in the endocardium of OVX and OVF groups. With ageing, ovariectomy leads to the loss of diastolic and global LV function while preserving ejection fraction. This model recapitulates many cardiovascular features present in HFpEF patients and may help understand the roles that ageing and oestrogen depletion play in early (pre-HFpEF) disease development.
Identifiants
pubmed: 30681142
doi: 10.1113/JP277479
pmc: PMC6442018
doi:
Substances chimiques
Estrogens
0
Collagen
9007-34-5
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1805-1817Subventions
Organisme : BLRD VA
ID : I01 BX003230
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK098717
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG047326
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.
Références
J Appl Physiol (1985). 2004 Feb;96(2):822-8
pubmed: 14555689
Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2132-7
pubmed: 15231502
Ann N Y Acad Sci. 2005 Jun;1052:75-90
pubmed: 16024752
Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H304-11
pubmed: 16143657
N Engl J Med. 2006 Jul 20;355(3):251-9
pubmed: 16855265
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1606-14
pubmed: 17878225
Nat Protoc. 2008;3(9):1422-34
pubmed: 18772869
Circ Heart Fail. 2009 Jul;2(4):303-10
pubmed: 19808353
Eur J Heart Fail. 2011 Jan;13(1):18-28
pubmed: 20685685
Endocrinology. 2011 Apr;152(4):1589-98
pubmed: 21303943
Pharmacol Ther. 2012 Jul;135(1):54-70
pubmed: 22484805
J Am Coll Cardiol. 2013 Oct 1;62(14):1280-1287
pubmed: 23871886
Am J Physiol Heart Circ Physiol. 2014 Mar 1;306(5):H628-40
pubmed: 24414072
Nat Rev Cardiol. 2014 Sep;11(9):507-15
pubmed: 24958077
Age (Dordr). 2014;36(4):9684
pubmed: 25062714
Med Clin North Am. 2015 May;99(3):521-34
pubmed: 25841598
J Am Coll Cardiol. 2016 Feb 16;67(6):671-673
pubmed: 26868692
Neth Heart J. 2016 Apr;24(4):275-86
pubmed: 26936157
J Gerontol A Biol Sci Med Sci. 2017 Feb;72(2):152-162
pubmed: 27006078
Circ Res. 2016 Jul 8;119(2):357-74
pubmed: 27390337
Circ Heart Fail. 2016 Oct;9(10):
pubmed: 27682440
Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H1031-H1043
pubmed: 28778911
JACC Basic Transl Sci. 2017 Dec;2(6):770-789
pubmed: 29333506
Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1670-H1683
pubmed: 30239232
Ann Biomed Eng. 1995 Mar-Apr;23(2):152-63
pubmed: 7605052
J Biomech. 1993 Jun;26(6):665-76
pubmed: 8514812
J Am Coll Cardiol. 1997 Dec;30(7):1872-7
pubmed: 9385921
J Am Coll Cardiol. 1998 Oct;32(4):1118-25
pubmed: 9768741